Adaptimmune Therapeutics PLC (ADAP)
Q3 2018 Earnings Conference Call
November 6, 2018 08:00 AM ET
Executives
Juli Miller - Director of IR
James Noble - CEO & Director
Rafael Amado - Chief Medical Officer
Adrian Rawcliffe - Chief Financial Officer
Analysts
Jonathan Chang - Leerink Partners
Marc Frahm - Cowen and Company
Robyn Karnauskas - Citi
Peter Lawson - SunTrust Robinson Humphrey
Michael Schmidt - Gugenheim
Ren Benjamin - Raymond James
Jim Birchenough - Wells Fargo Securities
Ying Huang - Bank of America Merrill Lynch
Presentation
Operator
Good day, ladies and gentlemen, and welcome to